Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis

NCT03887026 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Allergic Rhinoconjunctivitis

Interventions

DRUG: Norketotifen
DRUG: Placebo

Sponsor

Emergo Therapeutics, Inc.